MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.
Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O'Brien PC, Cha R, Knopman D, Petersen RC.
Jack CR Jr, et al.
Neurology. 2003 Jan 28;60(2):253-60. doi: 10.1212/01.wnl.0000042480.86872.03.
Neurology. 2003.
PMID: 12552040
Free PMC article.
Clinical Trial.